Summary
In a randomized, controlled clinical study, dextran-70, warfarin, or low-dose heparin were administered to patients undergoing total hip replacement on one surgical unit in an attempt to prevent deep venous thrombosis and pulmonary embolism. Calf vein thrombosis was detected by the 125I-fibrinogen uptake test. None of the methods prevented calf vein thrombosis (dextran-70, 51%; warfarin, 58-6%; heparin, 52-6%). Pulmonary embolism was completely prevented in patients treated with warfarin but occurred in 4% of patients treated with dextran-70 and 15-5% of those treated with low-dose heparin. The incidence of complications of therapy was small and comparable in each group. It is suggested that calf vein thrombosis is a frequent and in itself a non-serious complication of total hip replacement surgery and that emphasis might be placed more usefully on prevention of pulmonary embolism.
Introduction
Elective orthopaedic procedures such as total hip replacement performed on patients of advanced age pose a particular problem in management. There is a greater incidence of deep venous thrombosis (DVT) and pulmonary embolism (PE) in this than in any other group of surgical patients, with a DVT rate of 50-54% and pulmonary embolism rate of 4-12-5% (Evarts and Feil, 1971; Hampson et al., 1974; Morris, Henry and Preston, 1974 (Kakkar et al., 1972; Morris et al., 1974) in preventing calf thrombi, but other reports have not been confirmatory (Hampson et al., 1974; Harris et al., 1974) . (Evarts and Feil, 1971 ) and dextran-70 (Bonnar and Walsh, 1972) have also reduced the incidence of calf thrombosis dramatically but total prevention has been achieved rarely. Moreover, various authors have reported 'silent' pelvic vein thrombosis with subsequent pulmonary embolism in the absence of calf vein thrombosis in up to 50% of cases (Sevitt and Gallagher, 1959; Mavor et al., 1972; Harris et al., 1974) . The oral anticoagulants phenindione (Sevitt and Gallagher, 1959) and warfarin (Harris, Salzman and de Sanctis, 1967; Harris et al., 1972; Muckle, Forney and Bentley, 1974) (Muckle et al., 1974) .
In view of the uncertainty of the efficacy of current methods of preventing deep venous thrombosis and pulmonary embolism a prospective, randomized, controlled clinical trial was set up in one surgical unit, in which techniques of pre-, per-and postoperative management were as standard as possible. Previously, warfarin therapy had completely prevented pulmonary embolism following total hip replacement in this unit (Muckle et al., 1974 (Bonnar and Walsh, 1972 (1) Dextran (Table 1 ). Of fifty-one patients (eighteen male, thirty-three female) who received dextran-70, twenty-six had calf DVT (51%). (2) Warfarin (Table 2 ). Of fifty-eight patients who received warfarin (twenty-two male, thirty-six female), thirty-four (58-6%) had DVT. A review of the literature shows that complete prevention of calf thrombi has never been achieved in this high-risk group of patients by any agent. Moreover, 'silent' thrombosis may occur in the proximal deep veins in the absence of thrombi in the calf veins. Therefore, the use of the absence of calf vein thrombosis as a criterion of the success of a regime to prevent thromboembolism is invalid in this group of patients.
Pulmonary embolism
The results show that pulmonary embolism was not prevented by heparin or dextran-70 where the incidence was 15.8% and 4Y% respectively. In the dextran group the onset of embolism was postponed until 31 and 38 days after operation, but embolism was within 12 days of surgery in the three cases receiving heparin. In the fifty-eight patients receiving warfarin no pulmonary embolism occurred. This accords with the findings of Harris et al. (1967, 1974) that no emboli occurred in patients receiving warfarin following hip replacement procedures.
Complications of therapy were no greater with warfarin than with heparin and dextran-70. The incidence of wound haematomata was not significantly different in the three groups. Haemorrhage from other sites did not occur in any group, and the wound sepsis rate was zero. Warfarin was subjectively reported by the patients, and by the medical and nursing staff, to be the easiest therapy to administer, although it involves the most laboratory effort, cost and time, and dextran-70 the most difficult.
On the basis of this investigation the authors recommend the use of warfarin as a safe method for the prophylaxis of pulmonary embolism, following total hip replacement, in preference to dextran-70 or twice-daily subcutaneous heparin. Its effects might be increased by commencing administration before operation as suggested by Harris et al. (1974) .
